| Literature DB >> 26966686 |
Hao-Tsai Cheng1, Sen-Yung Hsieh2, Chang-Mu Sung1, Betty Chien-Jung Pai3, Nai-Jen Liu4, Carl P C Chen5.
Abstract
AIMS: Bile is an important body fluid which assists in the digestion of fat and excretion of endogenous and exogenous compounds. In the present study, an improved sample preparation for human bile was established. METHODS AND MATERIAL: The method involved acetone precipitation followed by protein extraction using commercially available 2D Clean-Up kit. The effectiveness was evaluated by 2-dimensional electrophoresis (2DE) profiling quality, including number of protein spots and spot distribution.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26966686 PMCID: PMC4757711 DOI: 10.1155/2016/5185317
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1Two-DE gel image of untreated bile sample was detected to have approximately 39 protein spots.
Figure 2Two-DE gel image of bile sample treated with 2D Clean-Up kit was detected to have approximately 52 protein spots.
Figure 3Two-DE gel image of bile sample treated with acetone precipitation method was detected to have approximately 170 protein spots.
Figure 4Two-DE gel image of bile sample treated with acetone first and then subsequently by 2D Clean-Up kit. This gel image was detected to have approximately 558 protein spots.
Number of detected protein spots on the 2DE gel images.
| Bile fluid treatment method ( | Number of protein spots |
|---|---|
| Untreated | 39 |
| 2D Clean-Up kit | 52 |
| Acetone precipitation method | 170 |
| Acetone followed by 2D Clean-Up kit | 558# |
#Comparison between acetone followed by 2D Clean-Up kit and the other 3 treatment methods (p < 0.05).
Comparisons of total protein concentrations after different bile fluid sample treatment methods.
| Bile fluid treatment method ( | Concentration in |
|---|---|
| Untreated | 0.797 ± 0.465 |
| 2D Clean-Up kit | 0.598 ± 0.213 |
| Acetone precipitation method | 1.478 ± 0.415# |
| Acetone followed by 2D Clean-Up kit | 0.866 ± 0.331 |
#Comparison between acetone followed by 2D Clean-Up kit and the other 3 treatment methods (p < 0.05).
Names of the protein spots identified in this study confirmed by mass spectrometry (MS).
| Sample | Score | Spot name | Description | Acces. | Mr | PI | Number of matched peptides | Seq. cov. (%) |
|---|---|---|---|---|---|---|---|---|
| 39 | 133 | HBB_HUMAN | Hemoglobin subunit beta | P68871 | 15.988 | 6.75 | 9 | 74% |
| 40 | 58 | FETUA_HUMAN | Alpha-2-HS-glycoprotein | P02765 | 39.3 | 5.43 | 7 | 19% |
| 41 | 112 | A1AT_HUMAN | Alpha-1-antitrypsin | P01009 | 46.707 | 5.37 | 11 | 36% |
| 43 | 102 | ZA2G_HUMAN | Zinc-alpha-2-glycoprotein | P25311 | 34.237 | 5.71 | 14 | 50% |
| 44 | 143 | ZA2G_HUMAN | Zinc-alpha-2-glycoprotein | P25311 | 34.237 | 5.71 | 18 | 54% |
| 45 | 71 | HPT_HUMAN | Haptoglobin | P00738 | 45.177 | 6.13 | 12 | 33% |
| 46 | 81 | HPT_HUMAN | Haptoglobin | P00738 | 45.177 | 6.13 | 12 | 33% |
| 47 | 90 | HPT_HUMAN | Haptoglobin | P00738 | 45.177 | 6.13 | 13 | 32% |
| 48 | 68 | ALBU_HUMAN | Serum albumin | P02768 | 69.321 | 5.92 | 14 | 23% |
| 50 | 69 | ALBU_HUMAN | Serum albumin | P02768 | 69.321 | 5.92 | 15 | 24% |
| 55 | 57 | OFD1_HUMAN | Oral-facial-digital syndrome 1 protein | O75665 | 116.599 | 5.82 | 14 | 18% |
| 57 | 97 | TRFE_HUMAN | Serotransferrin | P02787 | 77.014 | 6.81 | 16 | 18% |
| 58 | 72 | TRFE_HUMAN | Serotransferrin | P02787 | 77.014 | 6.81 | 13 | 15% |
| 63 | 58 | MIPEP_HUMAN | Mitochondrial intermediate peptidase | Q99797 | 80.589 | 6.6 | 13 | 19% |
| 67 | 57 | CCD73_HUMAN | Coiled-coil domain-containing protein 73 | Q6ZRK6 | 124.077 | 5.42 | 15 | 17% |
| 68 | 65 | CMIP_HUMAN | C-Maf-inducing protein | Q8IY22 | 82.922 | 6.54 | 13 | 23% |
| 71 | 102 | HBB_HUMAN | Hemoglobin subunit beta | P68871 | 15.988 | 6.75 | 9 | 74% |
| 73 | 66 | CCD73_HUMAN | Coiled-coil domain-containing protein 73 | Q6ZRK6 | 124.077 | 5.42 | 16 | 16% |
| 74 | 58 | DNJC8_HUMAN | DnaJ homolog subfamily C member 8 | O75937 | 29.823 | 9.04 | 5 | 29% |
| 75 | 57 | PRDX2_HUMAN | Peroxiredoxin-2 | P32119 | 21.878 | 5.66 | 6 | 38% |
| 77 | 60 | MACF4_HUMAN | Microtubule-actin cross-linking factor 1, isoform 4 | Q96PK2 | 669.721 | 5.2 | 24 | 6% |
| 78 | 76 | P2R3C_HUMAN | Serine/threonine-protein phosphatase 2A regulatory subunit B′′ subunit gamma | Q969Q6 | 53.282 | 5.07 | 13 | 23% |
| 79 | 105 | TTHY_HUMAN | Transthyretin | P02766 | 15.877 | 5.52 | 7 | 59% |
| 80 | 82 | TTHY_HUMAN | Transthyretin | P02766 | 15.877 | 5.52 | 6 | 55% |
| 84 | 62 | ZN774_HUMAN | Zinc finger protein 774 | Q6NX45 | 55.032 | 8.71 | 7 | 20% |